New blood pressure drug takes on amlodipine in overweight patients
Disease control
Not yet recruiting
This study compares a newer blood pressure drug, sacubitril/allisartan, to the standard drug amlodipine in 104 overweight or obese adults with high blood pressure. Participants will take one of the two drugs for 8 weeks, with dose adjustments if needed. The main goal is to see wh…
Phase: PHASE4 • Sponsor: Jing Liu • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC